Skip to content
HowShorted

SPRUCE BIOSCIENCES, INC. short interest in 2022

In 2022, SPRUCE BIOSCIENCES, INC.'s disclosed short interest ran from 2.15% of shares outstanding on 14 Jan 2022 to 2.90% on 30 Dec 2022, a change of +0.75 percentage points. The year's high was 2.90% on 30 Dec 2022 and its low 0.26% on 31 Aug 2022, averaging 1.46% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.80 days on 30 Dec 2022. Full history: SPRUCE BIOSCIENCES, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SPRUCE BIOSCIENCES, INC. in 2022

2022 in figures

Start of year
2.15% (14 Jan 2022)
End of year
2.90% (30 Dec 2022)
Change
+0.75 pp
High
2.90% (30 Dec 2022)
Low
0.26% (31 Aug 2022)
Average
1.46%
Highest days to cover
13.80 (30 Dec 2022)
SEC filings marked
9

Every report in 2022

SPRUCE BIOSCIENCES, INC. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20222.15%1.00results (8-K)
31 Jan 20221.93%1.00
15 Feb 20221.78%2.04
28 Feb 20221.70%2.54
15 Mar 20221.40%2.5510-K filed, results (8-K)
31 Mar 20221.33%1.82
14 Apr 20221.61%5.08
29 Apr 20221.65%2.39
13 May 20221.64%3.5510-Q filed, results (8-K)
31 May 20221.78%5.12
15 Jun 20221.83%1.00
15 Aug 20220.31%2.3710-Q filed, results (8-K)
31 Aug 20220.26%2.72
15 Sep 20220.32%2.37
30 Sep 20220.26%2.53
14 Oct 20220.36%2.97
15 Nov 20221.40%7.7610-Q filed, results (8-K)
30 Nov 20222.13%3.60
15 Dec 20222.50%11.21
30 Dec 20222.90%13.80

See also: SPRUCE BIOSCIENCES, INC.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.